Jaguar Health Inc (FRA:1JA)
€ 7.56 0 (0%) Market Cap: 11.12 Mil Enterprise Value: 31.00 Mil PE Ratio: 0 PB Ratio: 0.76 GF Score: 23/100

Jaguar Health, Inc. - Special Call Transcript

Jan 27, 2021 / 01:30PM GMT
Release Date Price: €35640.04
Operator

Good day, and welcome to the Jaguar Health Investor Call. Today's conference is being recorded.

Before I turn the discussion over to the presenters, I'd like to remind you that Jaguar Health Management may make forward-looking statements relating to such matters as continued growth prospects for the company, the company's cash needs, financing plans and the company's business strategy, the likelihood, timing and scope of possible regulatory approval and commercial launch of the company's product candidates. The timing and cost of clinical trials and other expenses, uncertainties regarding market acceptance of products, the impact of competitive products and pricing, industry trends, product and technology initiatives, including product and the development stage, which may not achieve scientific objectives or meet stringent regulatory requirements and ultimate impact of current coronavirus pandemic or any other health epidemic on the company's business, its clinical trials, its research programs, or the global economy as a whole.

Forward-looking statements are subject to risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot